National Biotechnology Safety Act
S 2697, the National Biotechnology Safety Act, establishes a National Science Foundation program to fund research on the environmental, health, and safety risks of biotechnology products like gene-edited crops or microbes. It authorizes $50 million annually (2026-2030) for research grants to universities, nonprofits, industry, and consortia, focusing on identifying unintended effects, managing risks, and monitoring gene drives. The bill also mandates a two-phase study by the National Academies to compare biotech tools with conventional methods and recommend risk-based regulatory approaches. This research aims to inform federal agencies (like USDA and EPA) and develop clearer safety standards for biotech products, directly affecting researchers, biotech developers, and regulators.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2025
Committee Review
Floor Vote
President
Introduced Sep 3, 2025
Last action Sep 3, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Sep 3, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Sep 3, 2025
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2697
Scope: US
Hi! I can help you understand S 2697. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline